Peijia Medical: Completed the first human clinical trial of the ReachTactile robot-assisted TAVR system

2025-04-06 18:29:25

Peijia Medical announced that the company has completed the first patient treatment in the first human clinical trial of the ReachTactile robot-assisted transcatheter aortic valve replacement (TAVR) system. The operation was performed by Professor Wang Yan and his team from the Affiliated Cardiovascular Hospital of Xiamen University, using the ReachTactile™ robot-assisted TAVR system to implant a TaurusElite® transcatheter aortic valve in a patient with severe aortic stenosis. ReachTactile is a robot-assisted TAVR system developed in-house by the company, providing an innovative and cost-effective solution for TAVR treatment.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Broadcom (AVGO.O) shares rose 5% after the market closed.
                            2025-04-08

                                    EVE Energy responds to US "reciprocal tariff" policy: no cost impact on existing contract deliveries
                            2025-04-08

                                    Tencent Holdings (00700.HK) repurchased 996,000 shares for HK$500.9 million on April 2.
                            2025-04-02

                                    Apple concept stocks in Hong Kong stocks fell, with Gowin Electronics (01415.HK) down nearly 10%, Sunny Optical Technology (02382.HK) down more than 9%, Q Technology (01478.HK) down 8.5%, AAC Technologies (02018.HK) down 7.7%, Foxconn Technology (02038.HK) and BYD Electronics (00285.HK) down more than 6%.
                            2025-04-09

                                    Foxconn: Sales in March were NT$552.1 billion, up 23% year-on-year.
                            2025-04-05